Abstract | PURPOSE: MATERIALS AND METHODS: H460 tumor-bearing mice were treated with intravenous paclitaxel, and 12, 24, 48 and 72 h later, 99mTc-C2A-GST was injected intravenously, and planar images were acquired at 2, 4 and 6 h postinjection on a dual-head gamma camera fitted with a pinhole collimator. Tumor-to-normal tissue ratios (T/NT) were calculated by ROI analysis and reflected specific binding of 99mTc-C2A-GST. Mice were sacrificed after 6-h imaging; caspase-3 as apoptosis executer was determined by flow cytometry; DNA fragmentation was analyzed by terminal deoxynucleotidytransferase mediated dUTP nick-end labeling (TUNEL) assay. Whereas nonspecific accumulation was estimated using inactivated C2A-GST. The imaging data were correlated with TUNEL-positive nuclei and caspase-3 activity. RESULTS: T/NT significantly increased after paclitaxel inducement, whereas it was low in untreated tumors (T/NT=1.24+/-0.23). In terms of % ID/g, activity in Group 2 (12 h), Group 3 (24 h), Group 4 (48 h) and Group 5 (72 h) after the treatment was 2.05+/-0.20, 3.02+/-1.01, 3.17+/-1.16 and 3.96+/-1.72, respectively. Whereas in the nontreated group, Group 1 % ID/g was 1.21+/-0.51. The radiotracer uptake was positively correlated to the apoptotic index (r=0.70, P<.01), as well as caspase-3 activity (r=0.75, P<.01). CONCLUSION: This study addresses the dynamics and feasibility of imaging non-small cell lung tumor apoptosis using 99mTc-labeled C2A.
|
Authors | Feng Wang, Wei Fang, Ming Zhao, Zizheng Wang, Shundong Ji, Yan Li, Yuming Zheng |
Journal | Nuclear medicine and biology
(Nucl Med Biol)
Vol. 35
Issue 3
Pg. 359-64
(Apr 2008)
ISSN: 0969-8051 [Print] United States |
PMID | 18355692
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents, Phytogenic
- Radiopharmaceuticals
- Synaptotagmin I
- Technetium
- Casp3 protein, mouse
- Caspase 3
- Paclitaxel
|
Topics |
- Animals
- Antineoplastic Agents, Phytogenic
(therapeutic use)
- Apoptosis
(drug effects)
- Carcinoma, Non-Small-Cell Lung
(diagnostic imaging, drug therapy)
- Caspase 3
(drug effects, metabolism)
- Cell Line, Tumor
- DNA Fragmentation
(drug effects)
- Disease Models, Animal
- Female
- Humans
- Injections, Intravenous
- Lung Neoplasms
(diagnostic imaging, drug therapy)
- Male
- Mice
- Paclitaxel
(therapeutic use)
- Protein Structure, Tertiary
- Radioligand Assay
(methods)
- Radionuclide Imaging
- Radiopharmaceuticals
(pharmacokinetics)
- Synaptotagmin I
(chemistry, drug effects)
- Technetium
(pharmacokinetics)
- Tissue Distribution
|